France replies to EU objections over its device proposals
This article was originally published in Clinica
The French government is continuing work on a decree to introduce tough new requirements for high-risk medical devices. This is despite opposition from other European member states which has prevented France from enforcing its new requirements before August 5 (see Clinica No 808, p 1).
You may also be interested in...
In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China - seeking US initial public offerings, adding further uncertainty over such plans and further stoking trade tensions.
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established class competition in the setting.
Kynmobi is an important approval for parent company Sumitomo Dainippon ahead of the loss of exclusivity for Latuda. Sunovion hopes to launch after COVID-19 social distancing requirements ease.